Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
Clinical trial NCT06433609 · RECRUITING
Trial details
- NCT number
- NCT06433609
- Sponsor
- Beijing GoBroad Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-05
- Primary completion
- 2027-03-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.